Ross Law on Muck Rack

Ross Law

Verified
United Kingdom
As seen in: GlobalData, MSN, Yahoo Finance, Yahoo, ADVFN, EIN News, Pharmaceutical-Technology.com, Yahoo Finanzas, Clinical Trials Arena, Citrus County Chronicle, Marion Citizen and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ross

Contact Ross, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke Original

|
By Ross Law 
| Medical Device Network
Penumbra was acquired by Boston Scientific in a $14.5bn megadeal announced in January 2026. Credit: Anusorn Nakdee / Shutterstock.com Penumbra has secured US Food and Drug Administration (FDA) clearance for THUNDERBOLT, expanding the company’s computer-assisted vacuum thrombectomy (CAVT) lineup to address acute ischemic stroke.
Open in Who Shared View Duplicates (2) Issue with article?

Wave Neuroscience wins FDA clearance for precision PTSD therapy

|
By Ross Law 
| Medical Device Network
According to data from the US Department of Veterans Affairs (VA), around 6% of the US population will have PTSD at some point in their lives. Credit: ArtemisDiana / Shutterstock.com The US Food and Drug Administration (FDA) has cleared Wave Neuroscience’s precision neuromodulation platform for post-traumatic stress disorder (PTSD) treatment, providing a personalised, biomarker-guided clinical treatment for US patients with the disorder.
Open in Who Shared Issue with article?

Wave Neuroscience wins FDA clearance for precision PTSD therapy

|
By Ross Law 
| Yahoo
TTField uses mild electrical fields that interrupt cancer cells' ability to divide. Credit: ArtemisDiana / Shutterstock. The FDA has cleared Wave Neuroscience’s precision neuromodulation platform for PTSD treatment, offering personalised therapy based on EEG-derived brain activity biomarkers and AI analysis.
Open in Who Shared Issue with article?
See all 3,145 licensed articles (3,156 Total)

Actions

Share this page

Get in touch with Ross

Contact Ross, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified